-
1.
公开(公告)号:US5616603A
公开(公告)日:1997-04-01
申请号:US451898
申请日:1995-05-26
申请人: Gary T. Borrett , John Kitteringham , Roderick A. Porter , Mark R. Shipton , Mythily Vimal , Rodney C. Young
发明人: Gary T. Borrett , John Kitteringham , Roderick A. Porter , Mark R. Shipton , Mythily Vimal , Rodney C. Young
IPC分类号: A61K31/40 , A61K31/403 , C07D209/88
CPC分类号: A61K31/40 , A61K31/403 , C07D209/88
摘要: A (+)or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate or hydrate thereof, processes for preparing said compounds and pharmaceutical compositions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists.
摘要翻译: 其中R 4为甲基或乙基的式(I)化合物或其盐,溶剂化物或水合物的(+)或( - )对映异构体,用于制备所述化合物和含有它们的药物组合物。 式(+)化合物是5-HT1样激动剂。
-
公开(公告)号:US5618948A
公开(公告)日:1997-04-08
申请号:US451846
申请日:1995-05-26
申请人: Gary T. Borrett , John Kitteringham , Roderick A. Porter , Mark R. Shipton , Mythily Vimal , Rodney C. Young
发明人: Gary T. Borrett , John Kitteringham , Roderick A. Porter , Mark R. Shipton , Mythily Vimal , Rodney C. Young
IPC分类号: C07D209/82 , C07D209/88
CPC分类号: C07D209/82
摘要: A (+) or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate or hydrate thereof, processes for preparing said compounds and pharmaceutical compositions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists. ##STR1##
摘要翻译: 其中R 4为甲基或乙基的式(I)化合物或其盐,溶剂化物或水合物的(+)或( - )对映异构体,用于制备所述化合物和含有它们的药物组合物。 式(+)化合物是5-HT1样激动剂。 (一)
-
公开(公告)号:US5618947A
公开(公告)日:1997-04-08
申请号:US446655
申请日:1995-07-18
申请人: Gary T. Borrett , John Kitteringham , Roderick A. Porter , Mark R. Shipton , Mythily Vimal , Rodney C. Young
发明人: Gary T. Borrett , John Kitteringham , Roderick A. Porter , Mark R. Shipton , Mythily Vimal , Rodney C. Young
IPC分类号: A61K31/40 , A61K31/403 , A61P25/04 , A61P25/06 , A61P43/00 , C07D209/88
CPC分类号: C07D209/88 , A61K31/40
摘要: A (+) or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate or hydrate thereof, processes for preparing said compounds and pharmaceutical compositions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists.
摘要翻译: PCT No.PCT / EP93 / 03627 Sec。 371 1995年7月18日第 102(e)日期1995年7月18日PCT 1993年12月16日PCT PCT。 出版物WO94 / 14772 日期:1994年7月7日,(I)其中R 4为甲基或乙基的式(I)化合物或其盐,溶剂化物或水合物的(+)或( - )对映异构体,用于制备所述化合物 和含有它们的药物组合物。 式(+)化合物是5-HT1样激动剂。
-
公开(公告)号:US5612331A
公开(公告)日:1997-03-18
申请号:US464615
申请日:1995-07-26
申请人: Roderick A. Porter , Mythily Vimal
发明人: Roderick A. Porter , Mythily Vimal
IPC分类号: A61K31/40 , A61K31/403 , A61P25/04 , A61P25/06 , C07D209/88
CPC分类号: C07D209/88
摘要: Compounds of formula (I), wherein R.sup.1 represents halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, hydroxy, NO.sub.2, --NR.sup.4 R.sup.5, R.sup.4 R.sup.5 NCO(CH.sub.2).sub.m --, R.sup.4 R.sup.5 NSO.sub.2 (CH.sub.2).sub.m --, R.sup.6 CONH(CH.sub.2)-.sub.m or R.sup.7 SO.sub.2 NH(CH.sub.2).sub.m --; R.sup.4 and R.sup.5 each independently hydrogen or C.sub.1-4 alkyl or NR?.sub.4 R.sup.5 represents a 5- to 7-membered heterocyclic ring, R.sup.6 represents hydrogen or C.sub.1-4 alkyl; R.sup.7 represents C.sub.1-4 alkyl; m is zero, 1 or 2; n is zero or 1 to 5; R.sup.2 and R.sup.3 each independently represent hydrogen, C.sub.1-6 alkyl or benzyl or --NR.sup.2 R.sup.3 represents a pyrrolidino, piperidino or hexahydroazepino ring, and A represents a bond, a C.sub.1-5 alkylene chain or a C.sub.3-5 alkenyle chain wherein the double bond is not adjacent the nitrogen atom; and salts thereof have affinity for the 5-HT.sub.1 -like receptor and are useful e.g. in the treatment of migraine.
摘要翻译: PCT No.PCT / EP93 / 03628 371日期:1995年7月26日 102(e)日期1995年7月26日PCT 1993年12月16日PCT公布。 WO94 / 14773 PCT出版物 (I)式(I)化合物,其中R 1表示卤素,C 1-4烷基,C 1-4烷氧基,羟基,NO 2,-NR 4 R 5,R 4 R 5 NCO(CH 2)m - ,R 4 R 5 NSO 2(CH 2) m-,R6CONH(CH2)-m或R7SO2NH(CH2)m-; R 4和R 5各自独立地为氢或C 1-4烷基或NR 4 4R 5表示5-至7-元杂环,R 6表示氢或C 1-4烷基; R 7表示C 1-4烷基; m为零,1或2; n为0或1〜5; R2和R3各自独立地表示氢,C1-6烷基或苄基或-NR2R3表示吡咯烷子基,哌啶子基或六氢氮杂环,A表示键,C1-5亚烷基链或C3-5链烯基,其中双键不相邻 氮原子 并且其盐对5-HT1样受体具有亲和力,并且可用于例如 在治疗偏头痛。
-
公开(公告)号:US4804658A
公开(公告)日:1989-02-14
申请号:US908126
申请日:1986-09-15
申请人: Paul W. Manley , Roderick A. Porter
发明人: Paul W. Manley , Roderick A. Porter
IPC分类号: A61K31/44 , A61P7/00 , A61P9/00 , A61P11/00 , A61P29/00 , C07D471/04 , A61K31/535
CPC分类号: C07D471/04
摘要: This invention relates to novel imidazopyridine derivatives useful in the treatment of diseases or disorders mediated by platelet-activating factor. This invention further relates to pharmaceutical compositions of such imidazopyridine derivatives.
摘要翻译: 本发明涉及可用于治疗由血小板活化因子介导的疾病或病症的新型咪唑并吡啶衍生物。 本发明还涉及这种咪唑并吡啶衍生物的药物组合物。
-
公开(公告)号:US4962106A
公开(公告)日:1990-10-09
申请号:US308349
申请日:1989-02-09
申请人: Paul W. Manley , Roderick A. Porter
发明人: Paul W. Manley , Roderick A. Porter
IPC分类号: C07D471/04
CPC分类号: C07D471/04
摘要: This invention relates to novel imidazopyridine derivatives useful in the treatment of disease or disorders mediated by platelet-activating factor. This invention further relates to pharmaceutical compositions of such imidazopyridine derivatives.
摘要翻译: 本发明涉及可用于治疗血小板活化因子介导的疾病或病症的新型咪唑并吡啶衍生物。 本发明还涉及这种咪唑并吡啶衍生物的药物组合物。
-
公开(公告)号:US06476028B1
公开(公告)日:2002-11-05
申请号:US09529338
申请日:2000-08-08
申请人: William E. Bondinell , James Chan , Roderick A. Porter , Joseph W. Venslavsky , Steven Dabbs , David T. Davies
发明人: William E. Bondinell , James Chan , Roderick A. Porter , Joseph W. Venslavsky , Steven Dabbs , David T. Davies
IPC分类号: A61K3153
CPC分类号: C07D401/04 , A61K31/454 , C07D401/14
摘要: A method of treating a CCR5-mediated disease state in mammals which comprises administering to a mammal in need of such treatment, an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
摘要翻译: 一种治疗哺乳动物中CCR5介导的疾病状态的方法,其包括向需要这种治疗的哺乳动物施用有效量的式(I)化合物或其药学上可接受的盐。
-
公开(公告)号:US5637593A
公开(公告)日:1997-06-10
申请号:US448544
申请日:1995-06-20
申请人: Roderick A. Porter , John G. Ward
发明人: Roderick A. Porter , John G. Ward
IPC分类号: A61K31/40 , A61K31/403 , A61K31/404 , A61K31/44 , A61K31/4427 , A61P9/00 , A61P25/04 , A61P25/06 , C07D209/14 , C07D209/16 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12
CPC分类号: C07D401/04 , C07D209/14 , C07D209/16 , C07D401/12 , C07D401/14 , C07D403/12
摘要: A compound of structure (I), in which A.sup.1 is O, S(O).sub.n in which n is 0, 1 or 2, NR, CH.sub.2, or CH(OH); A.sup.2 is a bond or CH.sub.2 ; or A.sup.1 A.sup.2 is CH.dbd.CH; R is hydrogen or C.sub.1-4 alkyl; R.sup.1 is an optionally substituted 6- to 10-membered aryl or heteroaryl ring; suitably R.sup.1 is an optionally substituted 6- 10-membered aryl ring such as phenyl or naphthyl; suitably R.sup.1 is optionally substituted 6- to 10-membered heteroaryl ring, containing from 1 to 4 nitrogen atoms; R.sup.2 is hydrogen, halogen, C.sub.1-4 alkyl, CN, NO.sub.2 or CF.sub.3 ; R.sup.3 is C(R.sup.4)(R.sup.5)CH.sub.2 NR.sup.6 R.sup.7, --CH.dbd.NNHC(NH)NH.sub.2 or a; R.sup.4 and R.sup.5 are independently hydrogen or C.sub.1-4 alkyl; R.sup.6 and R.sup.7 are the same or different and are each hydrogen or C.sub.1-4 alkyl or together with the nitrogen atom to which they are attached form a ring; R.sup.8 is hydrogen, C.sub.1-4 alkyl, or C.sub.3-6 alkenyl; the dotted lines represent an optional bond; and q and m are independently 1 or 2; and pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds are 5-HT.sub.1 -like agonists (or partial agonists) and as such are expected to have utility in medicine in the treatment and/or prophylaxis of migraine, and other conditions associated with cephalic pain, such as cluster headache, headache associated with vascular disorders and other neuralgia. They are also expected to have utility in the treatment of prophylaxis of portal hypertension. ##STR1##
摘要翻译: PCT No.PCT / EP93 / 03563 371日期:1995年6月20日 102(e)1995年6月20日PCT 1993年12月14日PCT PCT。 公开号WO94 / 14770 日期:1994年7月7日A结构(I)化合物,其中A 1为O,S(O)n,其中n为0,1或2,NR,CH 2或CH(OH); A2是键或CH2; 或A1A2是CH = CH; R是氢或C 1-4烷基; R1是任选取代的6-至10-元芳基或杂芳基环; 合适地R 1是任选取代的6- 10元芳基环,例如苯基或萘基; 合适地R 1是含有1至4个氮原子的任选取代的6至10元杂芳基环; R2是氢,卤素,C1-4烷基,CN,NO2或CF3; R3是C(R4)(R5)CH2NR6R7,-CH = NNHC(NH)NH2或a; R4和R5独立地是氢或C1-4烷基; R 6和R 7相同或不同,各自为氢或C 1-4烷基,或与它们所连接的氮原子一起形成环; R8是氢,C1-4烷基或C3-6烯基; 虚线表示可选的键; q和m独立地为1或2; 及其药学上可接受的盐,溶剂化物和水合物。 化合物是5-HT1样激动剂(或部分激动剂),因此预期在医学中可用于治疗和/或预防偏头痛以及与头痛相关的其它病症,例如丛集性头痛,与头痛相关的头痛 血管疾病等神经痛。 它们也预期可用于治疗门静脉高压的预防。 (一)图像(一)
-
公开(公告)号:US4837333A
公开(公告)日:1989-06-06
申请号:US49491
申请日:1987-05-14
申请人: Paul W. Manley , Roderick A. Porter , Mun F. Lai
发明人: Paul W. Manley , Roderick A. Porter , Mun F. Lai
IPC分类号: C07D233/60 , C07D521/00
CPC分类号: C07D231/12 , C07D233/56 , C07D249/08
摘要: This disclosure relates to a class of novel substituted alkylidene imidazole derivatives and pharmaceutically acceptable salts thereof. The disclosure further describes pharmaceutical compositions containing such compounds and to the use of such compounds and compositions as agents for selectively inhibiting the action of the enzyme thromboxane synthetase.
摘要翻译: 本公开涉及一类新的取代的亚烷基咪唑衍生物及其药学上可接受的盐。 本公开进一步描述了含有这些化合物的药物组合物,以及这些化合物和组合物作为选择性抑制酶血栓素合成酶作用的试剂的用途。
-
-
-
-
-
-
-
-